| |
|
      |
|
|
Abstracts
Activation and redistribution of c-Jun N-terminal
kinase/stress activated protein kinase in degenerating neurons in Alzheimer's
disease.
J Neurochem 2001 (January) 76(2): 435-441
Zhu X, Raina AK, Rottkamp CA, Aliev G, Perry G, Boux H, Smith MA
Cellular responses to increased
oxidative stress appear to be a mechanism that contributes to the varied
cytopathology of Alzheimer's disease (AD). In this regard, we suspect that
c-Jun N-terminal kinase/Stress activated protein kinase (JNK/SAPK), a major
cellular stress response protein induced by oxidative stress, plays an important
role in Alzheimer disease in susceptible neurons facing the dilemma of
proliferation or death. We found that JNK2/SAPK-alpha and JNK3/SAPK-ss were
related to neurofibrillary pathology and JNK1/SAP-Kgamma related to Hirano
bodies in cases of AD but were only weakly diffuse in the cytoplasm in all
neurons in control cases and in non-involved neurons in diseased brain. In this
regard, in hippocampal and cortical regions of individuals with severe AD, the
activated phospho-JNK/SAPK was localized exclusively in association with
neurofibrillar alterations including neurofibrillary tangles, senile plaque
neurites, neuropil threads and granulovacuolar degeneration structures (GVD),
completely overlapping with tau-positive neurofibrillary pathology, but was virtually
absent in these brain regions in younger and age-matched controls without
pathology. However, in control patients with some pathology, as well as in mild
AD cases, there was nuclear phospho-JNK/SAPK and translocation of
phospho-JNK/SAPK from nuclei to cytoplasm, respectively, indicating that the
activation and re-distribution of JNK/SAPK correlates with the progress of the
disease. By immunoblot analysis, phospho-JNK/SAPK is significantly increased in
AD over control cases. Together, these findings suggest that JNK/SAPK
dysregulation, probably resulting from oxidative stress, plays an important
role in the increased phosphorylation of cytoskeletal proteins found in AD.
|
|